Physician profile
Keith D Harbour
NPI 1518985316
$854.77
in general payments reported to CMS, 2019-2025
16 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $12.54 · 2021: $176 · 2022: $184 · 2023: $152 · 2024: $93.13 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $143.15 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $133.01 | 2021-2023 | |
| Novo Nordisk INC | $87.17 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.47 | 2019-2021 | |
| Glaxosmithkline, LLC. | $81.16 | 2024-2025 | Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $73.07 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $71.06 | 2022-2023 | Farxiga |
| Adlon Therapeutics L.P. | $38.20 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $37.32 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $21.23 | 2025 | Rexulti |
| Amgen INC. | $18.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.35 | 2019 | |
| Shire North American Group INC | $14.27 | 2019 | |
| Allergan, INC. | $12.54 | 2020 | |
| Pfizer INC. | $11.64 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Harbour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.